Aaron B. Beeler
Professor Beeler received a B.S. in Biology from Belmont University and a Ph.D. in May 2002 in Medicinal Chemistry from the University of Mississippi under Professor John M. Rimoldi. He joined Boston University as a Postdoctoral Research Associate under Professor John A. Porco in May 2002 and the CMLD-BU in May 2003 being appointed Assistant Director in March 2005. He led efforts in the Center’s library synthesis activities for over ten years and directed a collaborative project with MIT to develop an automated microflow synthesis system. In 2012, Aaron was promoted to Assistant Professor of Medicinal Chemistry at Boston University. The Beeler Research Group focuses on medicinal chemistry, technology development and the development of photochemical methodology for the synthesis of natural products and complex biorelevant chemotypes. https://www.beelerlab.com/.
Dr Andrew Carson-Stevens is an academic general practitioner and health services researcher leading research and pedagogical advances in how health and social care organizations learn from unsafe care experienced by patients and families. He convenes the Patient Safety Research Group (the ‘PISA group’) at the School of Medicine, Cardiff University, investigating the frequency and avoidability of healthcare-associated harm, and the development and implementation of interventions to mitigate risk to patients.
Dr Carson-Stevens is a long-standing adviser to the World Health Organization on patient safety and methodological adviser to the OECD Working Group for Patient-reported Safety Outcomes. He was a member of the WHO Taskforce responsible for formulating the content and recommendations of the WHO’s Global Patient Safety Action Plan (2021-2030).
Agnes Nogueira Gossenheimer
Graduated in Pharmacy from the Federal University of Rio Grande do Sul (UFRGS) (2010), Academic Master’s degree from the Postgraduate Program in Pharmaceutical Sciences at UFRGS (2013), Doctorate from the Postgraduate Program in Pharmaceutical Sciences at UFRGS (2018), with sandwich period at the University of Lisbon. She was Assistant Professor at the Faculty of Pharmacy at UFRGS. Postdoctoral student in the Postgraduate Program in Medical Sciences – Endocrinology at UFRGS. Head of Pharmaceutical Services at the State Health Department of the State of Rio Grande do Sul and responsible for Pharmaceutical Teleheath. She works mainly on the following topics: Treatment Adherence, Pharmaceutical Services, Clinical Pharmacy, Health Technology Assessments and Pharmaceutical Education.
Astrid Wiens Souza
Graduated in Pharmacy – Federal University of Paraná (UFPR) in 2001, Master (2009) and Ph.D. (2011) in Pharmaceutical Sciences – UFPR. Currently is an Adjunct professor at UFPR, where she coordinates the Post-graduate Program in Pharmaceutical Assistance (PPGASFAR-UFPR). She acts as a master and doctoral advisor in PPGASFAR-UFPR and in the Post-Graduate Program in Pharmaceutical Sciences – UFPR. She is member of REBRATS – Brazilian Network for Health Technology Assessment and coordinator of the Health Technology Assessment Center (NATS) at UFPR. She works mainly with the following themes: evidence-based health and health technology assessment, including systematic reviews, meta-analyses and economic evaluation.
Arben Merkoçi is currently ICREA Professor and director of the Nanobioelectronics & Biosensors Group at Institut Català de Nanociencia i Nanotecnologia (ICN2), a BIST centre situated at Autonomous University of Barcelona (UAB) campus (Bellaterra, Barcelona). After his PhD (1991) at Tirana University, in the topic of Ion-Selective-Electrodes (ISEs) designs and applications in clinical and environmental analysis, Dr. Merkoçi worked as postdoc at other European research centres and USA in the field of nanobiosensors and lab-on-a-chip technologies. His postdoc periods were followed by leading positions in several laboratories: (1997-2006) at Autonomous University of Barcelona and since 2006 in ICN2. Prof. Merkoçi research is focused on the design and application of cutting-edge nanotechnology and nanoscience-based biosensors with interest for diagnostics. He has published around 300 peer review research papers, is editor of several books dedicated to the field of nanomaterials integration and applications in biosensors. Prof. Merkoçi is Editor of Biosensors and Bioelectronics, the principal international journal devoted to research, design development and application of biosensors and bioelectronics, member of editorial board of Electroanalysis, Microchimica Acta and other journals.
Bibiana Verlindo de Araujo is Professor of Pharmacokinetics, Clinical Pharmacokinetics and Pharmacometrics at UFRGS, where she teaches in the Faculty of Pharmacy and in the Graduate Program of Pharmaceutical Sciences and Medical Sciences. She has a Pharmacy Bachelor’s Degree from the Federal University of Rio Grande do Sul and Ph.D. in Pharmaceutical Sciences from the same University. In 2009 she received an Honorable Mention by her Doctoral Thesis from CAPES. Her researches are focused in Pharmacokinetic/Pharmacodynamic modeling of antifungals, antimalarials and antidiabetics drugs, pharmacokinetics evaluation of new compounds and drug-loaded nanoparticles and microdialysis. Up to now she was advisor of 07 Master of Science Thesis, 03 Doctoral Thesis and more than 30 undergraduate students.
Carlos Alberto Franco Ballarati
Medicine: Graduate in Medicine PUC-SP Sorocaba in 1988. Medical Residence: Clinical Residence at Unicamp in 1989. Fellowship at Deustche Klinik fur Diagnostik – DKD – Wiesbaden Germany in 1990. Medical Residence: Clinical Pathology at FMUSP in 1990 – 1993. Specialization: Specialist title in Clinical Pathology in 1994 from the Sociedade Brasileira de Patologia Clínica/Medicina Laboratorial (SBPC/ML). PHD: Pathology from FMUSP in 2000. MBA: Healthcare Management from IBMEC-Insper / HIAE in 2007. Founder i9Med (POCT LAB) 2018. Founder I2H (Institute Development of brazilian health sector) nov 2016. Founder Consulta do Bem (startup) 2015. Consultant (Iprede – Instituto Butantan) 2013-2015. Board President SBPC//ML bi-annual 2012-2013. President SBPC/ML bi-annual 2010-2011. Scientific Director of SBPC/ML 2005-2009. Assistant -Director of Medial Saúde operational directorate of Total Laboratórios / Amcare associated with Johns Hopkins International Medicine 2008-2010. Technical Director of Labxis managing HSC, Unimed Paulistana, Sepaco, Hospital Santa Helena 2004-2008. General Coordinator of Hospital Sírio Libanês Laboratory1996-2006.
Ester Cerdeira Sabino
Dr Sabino obtained her medical degree at the University of Sao Paulo and started her scientific training in San Francisco in 1991 working on HIV. In Brazil she focused her carrier on Blood Safety. She served as Director of the Institute of Tropical Medicine from 2015-2019 and since then she is participating in the international effort to establish a rapid research response to new emerging treats. She has published more than 250 peer-reviewed papers and has directly trained over 50 pos graduation students.
Fernando B. Costa
• Pharmacist, mestrado and doctorate degree in Organic Chemistry (Natural Products Chemistry)
at the University of São Paulo (USP), and Post Doctoral Research (Chemoinformatics) at the Computer-Chemie Centrum, University of Erlangen-Nuremberg, Germany
• Associate Professor, Pharmacognosy, School of Pharmaceutical Sciences of Ribeirão Preto
• Teaching experience for undergraduate and graduate students
• Research experience in phytochemistry, evaluation of biological activities of natural products
and chemoinformatics applied to natural products
• Research alumni ambassador and Brazil Chair, University of Münster, Germany, 2018 and 2012
Germana Barata is a science communicator and researcher at the Laboratory of Advanced Studies in Journalism (Labjor) at the State University of Campinas (Unicamp). She is currently coordinating the Science Journalist Graduation Course at Unicamp, is a member of the Brazilian Association of Science Editors (ABEC) board, and has a grant in Productivity in Science Communication from CNPq.
Gustavo Mendes Lima Santos. General Manager of Medicines and Biological Products. Graduated in Industrial Pharmacy from the University of São Paulo (2001), Specialization in Sanitary Surveillance from FIOCRUZ (2007) and Master in Toxicology applied to Sanitary Surveillance from the State University of Londrina (2013). Experience of 18 years at Anvisa with performance in the areas of registration and clinical research of medicines.
Ilana Lopes Baratella da Cunha Camargo
At the FCFRP-USP, Ilana Camargo attended the 1st CIFARP while an undergrad student and pursued her Master ́s and Ph.D. Driven by her passion for microbiology, she first saw snow at the Biozentrum/UniBasel in Switzerland, joined tornados in Oklahoma City to visit the Oklahoma Health Sciences Center, and breathed the cold air of Boston at the Harvard University. As a post-doc, Ilana searched for Brucella abortus alive vaccines in a BL3 lab at the ICB-UFMG and had her first earthquake studying daptomycin resistance in S. aureus at the Juntendo University in Tokyo. Professor at the IFSC-USP since 2009, Ilana studies new antibiotic resistance mechanisms and helps with the antimicrobials discovery at the Laboratory of Molecular Epidemiology and Microbiology, LEMiMo. Married and mother of two boys, Ilana still belongs to the BrCAST and the Brazilian Society of Microbiology.
Dr. Ikhlas Khan is the Director of the National Center for Natural Products Research at the University of Mississippi. He received a D. Litt (Honoris Causa) from University of Hamdard, Delhi, India 2012; a B.S. in Chemistry in 1980 and a M.S. in Organic Chemistry in 1982 from the Aligarh Muslim University in Aligarh, India, as well as a Ph.D. in Pharmacy from the Institute fuer Pharmaceutische Biology in Munich, West Germany in 1987. His primary research interests include analytical fingerprinting for standardization of herbal products, and bio-analytical approaches to improvement of product quality and safety. He authored/co-authored over 800 original research articles, publications, or reviews. He has been invited to speaker at many events and served as a reviewer for several prestigious journals. He is a member of many scientific organizations and served on numerous committees. He is the recipient of numerous scientific awards.
Juliana da Silva
Juliana da Silva is graduated in Biology from the Pontifical Catholic University of Rio Grande do Sul (1989); MSc (1994), PhD (1999) and post-doctoral degree (2001) in Genetics and Molecular Biology from the Federal University of Rio Grande do Sul. Adjunct professor at the Lutheran University of Brazil – ULBRA since 2003, where she coordinates the Laboratory of Toxicological Genetics and acts as a master’s and doctoral advisor in the Post-Graduate Program in Cellular and Molecular Biology Applied to Health – PPGBioSaúde. Teacher also at La Salle University, and advisor in the Professional Master’s Degree in Health and Human Development -PPGSDH. Ex-president of the Association of Mutagenesis and Environmental Genomics (Mutagen-Brazil, 2018-2020). Currently is member of the Advisory Committee of Biological Sciences- FAPERGS (since 2015); is member of Scientific Councils of International Mutagenesis Associations (IAEMGS and ALAMCTA); and participate as an editorial board of Mutation Research – Genetic Toxicology and Environmental Mutagenesis. Experience in the area of Genetics, with emphasis on Environmental Mutagenesis and Monitoring. Her main research interests are: biomonitoring of environmental genotoxicity, mutagenesis of natural and synthetic products and human and occupational environmental exposure. Researcher level 1B CNPq (CNPq Research Productivity Program).
Lauro Tatsuo Kubota
Lauro Kubota got the degree in Chemistry from the State University of Londrina in 1986 and PhD in Chemistry from University of Campinas (Brazil) in 1993. He did postdoctoral studies at Lund University (Sweden) in 1997/98. He was lecturer at São Paulo State University from 1989 to 1994. He joined to University of Campinas in 1994 as Assistant Professor, where became Associate Professor in 2000 and Full Professor in 2009. He is a member of the São Paulo State Academy of Science (ACIESP), the Brazilian Academy of Science (ABC) and Fellow of Royal Society of Chemistry. He works in Chemistry with emphasis on Electroanalytical Chemistry for the development of sensors and biosensors employing novel materials.
Leonardo Fernandes Fraceto
Dr Leonardo Fernandes Fraceto, PhD, has a bachelor’s degree in Chemistry, master and PhD in Functional and Molecular Biology. He is currently an Associate Professor at UNESP, Campus Sorocaba. Actually, he is a Fellow from the Royal Society of Chemistry. He has experience in environmental nanotechnology, with an emphasis on health and environmental nanotechnology and applications of nanotechnology in agriculture. He is Associate Editor from journals (Scientific Reports, PLOS one, Frontiers in Environmental Sciences, Energy, Ecology and Environment, Journal of Nanobiotechnology). Dr. Fraceto has published more than 24 papers with a h- index of 49 and more than 9000 citations (google scholar).
Ljubica Tasic holds a Bachelor’s and Master’s in chemistry from the Faculty of Chemistry, Belgrade University, Belgrade, Serbia, and a Ph.D. from the Chemistry Institute of the University of Campinas – UNICAMP, Campinas, Brazil. She carried out the post-doctorate research at the National Synchrotron Light Laboratory (LNLS) from 2002-2004. In October 2004 became a Professor in the Organic Chemistry Department of the Chemistry Institute of the University of Campinas, where she leads a research group in Biological Chemistry. Her principal interests are understanding the modified metabolic pathways that lead to or provoke diseases, elucidate diseases’ molecular basis, and the use of Magnetic Resonance.
Luiz Gonzaga de França Lopes
Dr. Lopes received bachelor’s degree in Chemistry from the Federal University of Rio Grande do Norte (1992) and a PhD in Physics and Chemistry from the University of São Paulo (1997). He has held post-doctoral degrees in the United States, 1997-1998 at Boston College and visiting researcher at National Cancer Institute/NIH in 2010-2011. He was director of the division of inorganic chemistry of the Brazilian Society of Chemistry in the 2012-2014 biennium, being now the vice president of SBQ. He was coordinator of the Graduate Programs in Inorganic Chemistry (2003-2008) and in Chemistry (2009-2010, 2015-2019). He is currently a full professor at the Federal University of Ceará. He has experience in Chemistry, with emphasis on Bio-Inorganic Chemistry, working mainly on the following topics: NO-releasing metallic complexes, sGC activators, anti-tubercrostatic metal complexes, etc.
Luis Monteiro Rodrigues
Monteiro Rodrigues holds a MSc and a PhD degree in human physiology, being the head of the research unit CBIOS (Universidade Lusófona, Lisboa P) where he leads the Modelling Systems lab. Skin Physiology, Microcirculatory Physiology and Pathophysiology and are main themes of his interest. Founder and current Chairman of the EEMCO Group (2017-) and the Portuguese Physiological Society (2019-).
Dr. Kit Lam is a Distinguished Professor of the Department of Biochemistry and Molecular Medicine; Professor of Medicine at the Division of Hematology/Oncology at the University of California, Davis, USA. He received a B.S. in Microbiology in 1975 from Texas University, Austin; a PhD and Post Doc in Oncology from the University of Wisconsin in 1980, as well as an MD from Stanford University in 1984. He then went on to Residency in Internal Medicine and a Clinical Fellow in Hematology/Oncology at the University of Arizona in 1987 and 1989, respectively. He is a physician-scientist, a board-certified internist and medical oncologist, and an expert in combinatorial chemistry, chemical biology, drug development, molecular imaging, nanotherapeutics, and biomaterial. He invented the one-bead-one-compound (OBOC) combinatorial library methods that have been used for the development of cancer targeting ligands. He was one of the founding scientists of Selectide Corporation in Tucson, which was later acquired by Sanofi. He published over 380 peer reviewed articles and he is an inventor of over 30 issued patents. He has been serving on the NCI Board of Scientific Counsellor for Basic Sciences since November 2016.
Kim Lewis is a University Distinguished Professor and Director, Antimicrobial Discovery Center at Northeastern University in Boston, a Fellow of the American Society of Microbiology, and a Fellow of the American Association for the Advancement of Science.
He obtained his Ph.D. in Biochemistry from Moscow University, and has been on the Faculty of MIT, University of Maryland, and Tufts University prior to coming to Northeastern.
Dr. Lewis is a recipient of the NIH Director’s Transformative Award and is a Clarivate highly cited researcher. He works on mechanisms of antibiotic tolerance and antibiotic discovery.
Maria Cristina Nonato
I am a physicist with a PhD in applied physics (Physics Institute at São Carlos-USP) and a pos-doc in chemical biology (Cornell University) and medicinal chemistry (Broad Institute at Harvard and MIT). I have over 25 years of experience in the field of Structural Biology, integrating biophysics chemistry and biology with the goal of advancing human health, in particular in the fields of neglected and rare diseases. My research is focused on Structural Biology applied to drug discovery with special emphasis in Protein Crystallography, Enzyme kinetics, Biophysical and Biochemical characterization of protein targets, and ligand screening by both in silico and in vitro techniques. I have a dedicated career as research mentor, having supervised 10 MSc, 7 PhDs as supervisor and 3 PhDs as co-supervisor, 7 pos-docs and 20 undergraduates. I am a disseminator of science, giving speeches to highlight the important role of women in science.
Maria Auxiliadora Martins
Maria Auxiliadora Parreiras Martins is Associate Professor at the Department of Pharmaceutical Products at the Federal University of Minas Gerais (UFMG). She is a specialist in Public Health and Hospital Pharmacy, Master in Pharmaceutical Sciences at UFMG School of Pharmacy, PhD in Health Sciences: Infectiology and Tropical Medicine at UFMG School of Medicine and post-doctoral researcher at Boston University, USA. She is member of the Institute for Safe Medication Practices-ISMP Brazil. The research issues are Hospital Pharmacy and Clinical Pharmacy, with emphasis on patient safety, oral anticoagulation and drug-induced renal failure.
Mauricio da Silva Baptista
Mauricio S. Baptista is professor of Biochemistry at the University of São Paulo (USP, Brazil). He earned Bachelor (1990) and Master (1992) degrees in Biochemistry from USP and holds a doctoral degree (1996) in Chemistry from Marquette University (USA). He did his post-doctoral training at UW-Madison (1997) and was visiting professor (2006) at the Université Joseph Fourier (Grenoble-France). His main interests are photochemistry/photobiology, membranes/interfaces and mechanisms of cell death, where he published over 200 papers, 15000+ citations, h=52. He is CNPq research level 1A and serves as treasure of the Brazilian Biochemical Society, member of the board of the American Society of Photobiology, member of the São Paulo state academy of science. Is co-editor in chief of J. Photochem Photobiol. B., associated editor of Scientific Reports (Nature). Received the huma
Norberto Peporine Lopes
Norberto Peporine Lopes is a professor da Organic Chemistry at the University of São Paulo. Lopes is a member Brazilian Academy of Science and Past President of the Brazilian Chemical Society. He coordinates NIDUS-InovaUSP (Inovation Training center for companies and entrepreneurs).
Paulo Artaxo is a professor of environmental physics at the University of São Paulo. He is a member of the IPCC (Intergovernmental Panel on Climate Change) and several other international committees. He coordinates the FAPESP Climate Change Program.
Patrick J. Parsons
Dr. Patrick Parsons is the Director of the Division of Environmental Health Sciences and Chief of the Laboratory of Inorganic and Nuclear Chemistry at the New York State Department of Health’s Wadsworth Center. He also a Professor of Environmental Chemistry in the Department of Environmental Health Sciences at the University at Albany. Dr. Parsons gained his Ph.D. from the University of London, England, and was a Visiting Fellow at NIH. His CDC-funded research focuses on how trace elements affect human health and how human biomonitoring can be used to assess exposure using state-of-the-art analytical techniques based on atomic spectrometry. His NIEHS-funded research has focused on developing improved exposure measurements using X-ray fluorescence (XRF) spectrometry. Dr. Parsons has published more than 200 papers and 12 book chapters on trace element analysis and atomic spectrometry. https://www.wadsworth.org/research/laboratories/parsons
Raquel Herrera Comoglio is MD (Cordoba National University, Argentina), MSc in Pharmacoepidemiology (PE) (Universidad Autonoma de Barcelona, Spain), and PhD in PE and Pharmacovigilance (PV), (Université de Bordeaux, France).
She works as an Assistant Professor, Hospital Unit of Internal Medicine, School of Medicine, Cordoba National University, Argentina and Head of a University Hospital PV Service and Director and teacher of a number of PV courses.
She is voluntary consultant member of the Uppsala Monitoring Centre (UMC) Signal Review Panel. She edited, in collaboration with the UMC, two Pharmacovigilance books in Spanish, freely downloadable from www.academia.edu
In the past, she acted as Coordinator of the ISoP Latin-American chapter from October 2009 to March 31, 2021; as Scientific coordinator of ISoP Latin-American chapter Symposia (2014 to 2018), and as an honorary member of the Drug Safety Case Reports Editorial Board.
Dr. Renata Lopez graduated in Pharmacy-Biochemistry and has a Ph.D. in Pharmaceutical Sciences obtained at the University of Sao Paulo (FCFRP-USP). She was a visiting researcher at the University of Geneva and did a 2-years sabbatical at MIT. She is currently an Associate Professor at the FCFRP-USP and leads the Centre for Innovation in Nanostructured Systems and Topical Administration (NanoTop). Her research is focused on nanobiotechnology and non-invasive drug delivery routes. She has published numerous peer-reviewed articles and has supervised more than 30 graduate fellows. She is a member of the INCT-Nanofarma and the Advisory Board of the ABCF. In 2019, she founded the CRS Brazilian Local Chapter and is the current president.
Dr Edrada-Ebel currently heads the Natural Products Metabolomics Group (NPMG) at the Strathclyde Institute of Pharmacy and Biomedical Sciences and is currently author of more than 100 publications and two patents on marine natural products. Her expertise comprises both natural products isolation and structure elucidation with modern spectroscopic techniques. She has won awards (i.e. Planta Medica’s Most Innovative Paper in 2017) and international fellowships (with the Royal Melbourne Institute of Technology as one of them) on the application of metabolomics on natural products research. At present, she has a series of on-going projects on the application of metabolomics to identify and biotechnologically optimize the production of bioactive secondary metabolites in marine-derived microorganisms.
Graduated in Pharmacy (2011). Master by the Postgraduate Program in Translational Medicine at the Federal University of São Paulo (UNIFESP, 2013).
PhD from the Federal University of São Paulo (UNIFESP). Researcher active in the development of projects on the major theme of Skin Aging; Clínical Studies and Drug Delivery Systems.
Post-doctoral in the Pharmaceutical Sciences Program at Unicamp, working in the large area of molecular and clinical characterization of mature/senile skin, as well as the development of products for skin care with dermatoporosis.
Professor of modular disciplines in Cosmetology; Applied Cosmetology to the Aesthetic area; Skin and Scalp Dermatosis; Technology and development of emulsions and polymeric systems. He currently works in the area of Innovation and Research at the Innovation Center of the Natura&Co Group (Natura; The Body Shop; Avon and Aesop).
Full Professor of the Department of Pharmacology at Escola Paulista de Medicina of Universidade Federal de São Paulo (UNIFESP), has a degree in Pharmacy and Biochemistry of the University of São Paulo; Ms and Ph.D. in Pharmacology at Escola Paulista de Medicina, UNIFESP. Postdoctoral studies at Thomas Jefferson University, Philadelphia and at the National Institutes of Health (NIH), Bethesda, USA. Visiting Researcher at NIH and a fellow at Fogarty Foundation. Estabished the High Resolution Microscopy and Confocal Facilities and is a Chief of the Cell Signaling and Death Laboratory at UNIFESP. Member of the National Council of Science and Technology (CCT). Member of the Board of Directors of the International Cell Death Society (ICDS). Develops research projects in Neuroscience, cell death and autophagy with funding from FAPESP, CAPES, FINEP and CNPq. CNPq
Sara K. Quinney
Sara K. Quinney, Pharm.D., Ph.D., is an Associate Professor in the Department of Obstetrics and Gynecology and Medicine at Indiana University. She received her Pharm.D. and Ph.D. in from Purdue University and completed clinical pharmacology and bioinformatics fellowships at Indiana University. Dr. Quinney utilizes in vitro, clinical and bioinformatics data to develop quantitative pharmacology models to study drug disposition and response in special populations, especially pregnant women. She has expertise in pharmacometrics, particularly in physiologically based pharmacokinetic (PBPK) modeling. Dr. Quinney serves as the Associate Director of the Indiana Clinical and Translational Sciences Institute Disease and Therapeutic Response Modeling Program, and the co-Director of the Indiana University Center for Pharmacogenetics and Therapeutics Research in Maternal and Child Health (PregMed).
Sérgio Luiz Oliveira
R&D Director and Fellow at Johnson & Johnson Brazil
Sérgio is Graduated in Chemistry and Mathematics by Faculdades Oswaldo Cruz and University of Vale do Paraiba (UNIVAP), respectively. M.Sc in Biomedical Engineering – Photobiology and Sun Protection by UNIVAP/UNICAMP and has MBA from FGV. He is Coordinator of the Sun Protection Technical Group at ABIHPEC; Leader of the Brazilian scientific delegation for ISO – TC217 GT7 – Methodologies for sun protection; member of ISO subteams in alternative sun protection methodologies, and member of the Science and Technology Council at ABHIPEC.
Sergio has a broad experience directing multifunctional R&D teams, such as Clinical Strategy&Operations, R&D Analytical, R&D Microbiology, R&D Stability of Products, and in vitro efficacy. Solid experience on consumer products development, comprising Sun Care, Skin Care and Hair Care for Adult and Baby markets; Feminine Health; Oral Care; OTC and Wound Care.
Tadachika Koganezawa is an Assistant Professor of the Faculty of Medicine, University of Tsukuba, Japan. He is a Principle Investigator of the Neurophysiology laboratory, a Deputy Director of the Sao Paulo Office, and chairs of International Committees of the Graduate Programs of Medical Sciences and Neurosciences.
Teresa Dalla Costa
Teresa Dalla Costa is a Full Professor at Federal University of Rio Grande do Sul (UFRGS), CNPq fellow, and leader of the Pharmacokinetics and PK/PD Modeling Laboratory at UFRGS. Her research interests are the infection effect on antimicrobials tissue distribution, PK/PD modeling of antimicrobials and antifungals; pharmacokinetic alterations due to drug´s nanoencapsulation. She published more than 145 scientific papers and advised more than 40 graduate students. She is co-Coordinator of the Ibero-American Pharmacometrics Network – RedIF, Executive Director of the Brazilian Society of Pharmacology and Experimental Therapeutics – SBFTE (2021-2013), member of the Consulting Board of the Brazilian Association of Pharmaceutical Sciences – ABCF (2021-2022), and member of the CNPq Advisory Committee in Pharmacy (2020-2023).
Dr. Virna Schuck has over 16 years of experience in Pharmaceutical Development, working across the Discovery and Development Phases. Throughout her professional career, Dr. Schuck’s work focused on understanding the pharmacokinetics of novel compounds and integrating nonclinical and clinical PK/PD data to drive clinical pharmacology strategies and dosing recommendation. She has experience working as a member of multidisciplinary project teams supporting the development of small and large molecules; and as a project leader of Quantitative Clinical Pharmacology teams responsible for delivering exposure-response and PK/PD analysis to support data driven decisions and regulatory submissions.
Dr. Virna Schuck has a bachelor degree in Pharmacy and Masters in Pharmaceutical Sciences from the Federal University of Rio Grande do Sul – UFRGS- Brazil, and a PhD in Pharmaceutical Science from the College of Pharmacy, University of Florida.
Valdes Roberto Bollela
1. Associate Professor in the Tropical and Infectious Diseases Division, Internal Medicine Department of Ribeirão Preto School of Medicine, University of São Paulo (FMRP-USP) – Brazil
2. Coordinator of Drug-resistant tuberculosis reference Center at Hospital das Clínicas of FMRP-USP
3. Global Faculty Member at Foundation for Advancement of Medical Education and Research (FAIMER) Institute – Philadelphia-USA
4. Core Faculty Member at FAIMER Brazil Regional Institute from Foundation for Advancement Of Medical Education And Research